AI takes aim at lung cancer: smarter radiation doses tested in new trial
NCT ID NCT05802186
First seen Nov 01, 2025 · Last updated Jun 01, 2026 · Updated 26 times
Summary
This study tests whether artificial intelligence (AI) can help doctors choose the right radiation dose for people with lung cancer or lung tumors that have spread from other cancers. About 70 participants will receive a precise type of radiation called SBRT, with the dose guided by an AI tool. The goal is to see if this personalized approach can better control tumors and reduce side effects compared to standard dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.